RAPS is closely monitoring developments in the Coronavirus (COVID-19) outbreak. See our public safety page for the latest updates.

Regulatory Focus™ > News Articles > Clearance and Approval Pathways for Diagnostics

Clearance and Approval Pathways for Diagnostics

Posted 01 March 2011 | By

Personalized medicine is a rapidly evolving area as therapeutic decisions based upon single test results become more common. Physicians have always used personalized medicine as they try to fit a therapy to a patient; however, personalized medicine has been recently taken to a new level of application. Exploration of the biology of disease and treatment at the molecular level are enabling physicians to use patients' genetic and protein information to provide the right therapy to the right patient at the right time.

Regulatory Focus newsletters

All the biggest regulatory news and happenings.

Subscribe

Regulatory Focus™ is doing essential, non-biased journalism during this unprecedented time. We appreciate your support as we bring you the news and intelligence you need to make an impact on global healthcare.

Regulatory Focus™ provides the intelligence you need to impact global healthcare during this crisis. Thank you for your support.